Related Experiment Video
Updated: Feb 7, 2026
Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
Published on: November 9, 2018
Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease
1Second Department of Medicine, Kurume University School of Medicine, Japan.
Abstract:
Neutrophils play a predominant role in inflammatory and immune reactions in inflammatory bowel disease. It is well established that the level of myeloperoxidase, a constituent of neutrophil azurophil granules, reflects the number of neutrophil. We examined the usefulness of determining stool levels of myeloperoxidase in patients with inflammatory bowel disease. Myeloperoxidase levels in stool extracts were measured using a radio-immunoassay in 33 patients with ulcerative colitis, 32 with Crohn's disease, 9 inflammatory disease controls and 15 normal controls. Stool levels of myeloperoxidase in active inflammatory bowel disease patients increased significantly, and correlated with laboratory parameters and endoscopic grade of inflammation. A paired analysis showed a decrease in myeloperoxidase levels after the resolution of disease exacerbation. These results suggest that stool myeloperoxidase is a simple, noninvasive, and relevant marker of disease activity.
Insights
Stool myeloperoxidase is a useful, noninvasive marker for inflammatory bowel disease (IBD) activity. Elevated levels in active IBD correlate with disease severity and decrease upon remission, aiding in patient monitoring.
Area of Science:
- Gastroenterology
- Immunology
- Clinical Diagnostics
Background:
- Neutrophils are key players in inflammatory bowel disease (IBD) pathogenesis.
- Myeloperoxidase (MPO), found in neutrophil granules, serves as a marker for neutrophil presence.
- Quantifying stool MPO may offer a noninvasive method to assess IBD activity.
Purpose of the Study:
- To evaluate the utility of stool myeloperoxidase (MPO) levels as a marker for disease activity in patients with inflammatory bowel disease (IBD).
Main Methods:
- Radio-immunoassay was used to measure stool MPO levels.
- Study included 33 ulcerative colitis patients, 32 Crohn's disease patients, 9 inflammatory disease controls, and 15 healthy controls.
- Correlation with laboratory parameters and endoscopic inflammation scores was assessed.
Main Results:
- Stool MPO levels were significantly elevated in active IBD patients.
- MPO levels correlated positively with laboratory markers and endoscopic disease severity.
- A decrease in stool MPO was observed following successful treatment of disease exacerbations.
Conclusions:
- Stool myeloperoxidase is a simple, noninvasive, and relevant biomarker for monitoring inflammatory bowel disease activity.
- This marker can aid in assessing disease severity and response to treatment.
- Further research can explore its integration into routine clinical practice for IBD management.
More Related Videos
Related Concept Videos
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...